Literature DB >> 27003493

Fracture Prediction With Modified-FRAX in Older HIV-Infected and Uninfected Men.

Michael T Yin1, Stephanie Shiau, David Rimland, Cynthia L Gibert, Roger J Bedimo, Maria C Rodriguez-Barradas, Katherine Harwood, Josh Aschheim, Amy C Justice, Julie A Womack.   

Abstract

BACKGROUND: FRAX is a validated, computer-based clinical fracture risk calculator that estimates the 10-year risk of major osteoporotic (clinical spine, forearm, hip, or shoulder) fracture, and hip fracture alone. It is widely used for decision making in fracture prevention, but it may underestimate the risk in HIV-infected individuals. Some experts recommend considering HIV as a cause of secondary osteoporosis when calculating FRAX in HIV-infected individuals.
METHODS: From the Veterans Aging Cohort Study Virtual Cohort, we included 24,451 HIV-infected and uninfected men aged 50-70 years with complete data in the year 2000 to approximate all but 2 factors (ie, history of secondary osteoporosis and parental hip fracture) for modified-FRAX calculation without bone density and 10-year observational data for incident fragility fracture. The accuracy of the modified-FRAX calculation was compared by the observed/estimated (O/E) ratios of fracture by HIV status.
RESULTS: The accuracy of modified-FRAX was less for HIV-infected [O/E = 1.62, 95% confidence interval (CI) 1.45 to 1.81] than uninfected men (O/E = 1.29, 95% CI: 1.19 to 1.40), but improved when HIV was included as a cause of secondary osteoporosis (O/E = 1.20, 95% CI: 1.08 to 1.34). However, only 3%-6% of men with incident fractures were correctly identified by the modified-FRAX using accepted FRAX thresholds for pharmacologic therapy.
CONCLUSIONS: Modified-FRAX underestimated the fracture rates more in older HIV-infected than in otherwise similar uninfected men. The accuracy improved when HIV was included as a cause of secondary osteoporosis, but it still performed poorly for case finding. Further studies are necessary to determine how to use FRAX or define an HIV-specific index to risk stratify for screening and treatment in older HIV-infected individuals.

Entities:  

Mesh:

Year:  2016        PMID: 27003493      PMCID: PMC4942335          DOI: 10.1097/QAI.0000000000000998

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  23 in total

Review 1.  Pitfalls in the external validation of FRAX.

Authors:  J A Kanis; A Oden; H Johansson; E McCloskey
Journal:  Osteoporos Int       Date:  2011-11-26       Impact factor: 4.507

2.  The combination of FRAX and Ageing Male Symptoms scale better identifies treated HIV males at risk for major fracture.

Authors:  Jessica Pepe; Andrea M Isidori; Mario Falciano; Giancarlo Iaiani; Alessandra Salotti; Daniele Diacinti; Romano Del Fiacco; Emilia Sbardella; Cristiana Cipriani; Sara Piemonte; Elisabetta Romagnoli; Andrea Lenzi; Salvatore Minisola
Journal:  Clin Endocrinol (Oxf)       Date:  2012-11       Impact factor: 3.478

3.  Use and misuse of the receiver operating characteristic curve in risk prediction.

Authors:  Nancy R Cook
Journal:  Circulation       Date:  2007-02-20       Impact factor: 29.690

4.  FRAX and the assessment of fracture probability in men and women from the UK.

Authors:  J A Kanis; O Johnell; A Oden; H Johansson; E McCloskey
Journal:  Osteoporos Int       Date:  2008-02-22       Impact factor: 4.507

5.  Hepatitis C co-infection and severity of liver disease as risk factors for osteoporotic fractures among HIV-infected patients.

Authors:  Naim M Maalouf; Song Zhang; Henning Drechsler; Geri R Brown; Pablo Tebas; Roger Bedimo
Journal:  J Bone Miner Res       Date:  2013-12       Impact factor: 6.741

6.  Physiologic frailty and fragility fracture in HIV-infected male veterans.

Authors:  Julie A Womack; Joseph L Goulet; Cynthia Gibert; Cynthia A Brandt; Melissa Skanderson; Barbara Gulanski; David Rimland; Maria C Rodriguez-Barradas; Janet Tate; Michael T Yin; Amy C Justice
Journal:  Clin Infect Dis       Date:  2013-02-01       Impact factor: 9.079

7.  Low bone mineral density, renal dysfunction, and fracture risk in HIV infection: a cross-sectional study.

Authors:  Alexandra Calmy; Christoph A Fux; Richard Norris; Nathalie Vallier; Cécile Delhumeau; Katherine Samaras; Karl Hesse; Bernard Hirschel; David A Cooper; Andrew Carr
Journal:  J Infect Dis       Date:  2009-12-01       Impact factor: 5.226

8.  FRAX and risk of vertebral fractures: the fracture intervention trial.

Authors:  Meghan G Donaldson; Lisa Palermo; John T Schousboe; Kristine E Ensrud; Marc C Hochberg; Steven R Cummings
Journal:  J Bone Miner Res       Date:  2009-11       Impact factor: 6.741

9.  Clinician's Guide to Prevention and Treatment of Osteoporosis.

Authors:  F Cosman; S J de Beur; M S LeBoff; E M Lewiecki; B Tanner; S Randall; R Lindsay
Journal:  Osteoporos Int       Date:  2014-08-15       Impact factor: 4.507

10.  European guidance for the diagnosis and management of osteoporosis in postmenopausal women.

Authors:  J A Kanis; E V McCloskey; H Johansson; C Cooper; R Rizzoli; J-Y Reginster
Journal:  Osteoporos Int       Date:  2012-10-19       Impact factor: 4.507

View more
  16 in total

1.  Proteinuria Is Associated With Increased Risk of Fragility Fracture in Men With or at Risk of HIV Infection.

Authors:  Anda Gonciulea; Ruibin Wang; Keri N Althoff; Michelle M Estrella; Deborah E Sellmeyer; Frank J Palella; Jordan E Lake; Lawrence A Kingsley; Todd T Brown
Journal:  J Acquir Immune Defic Syndr       Date:  2019-07-01       Impact factor: 3.731

2.  Increased Fragility Fracture Rates in Older Men With Osteomyelitis.

Authors:  Evelyn Hsieh; Stephanie Shiau; Olivia Nolan; Cynthia L Gibert; Roger J Bedimo; Maria C Rodriguez-Barradas; Amy C Justice; Julie A Womack; Michael T Yin
Journal:  Clin Infect Dis       Date:  2019-09-13       Impact factor: 9.079

Review 3.  Bone health in HIV and hepatitis B or C infections.

Authors:  Emmanuel Biver; Alexandra Calmy; René Rizzoli
Journal:  Ther Adv Musculoskelet Dis       Date:  2016-10-07       Impact factor: 5.346

Review 4.  HIV and Aging: Reconsidering the Approach to Management of Comorbidities.

Authors:  Kristine M Erlandson; Maile Y Karris
Journal:  Infect Dis Clin North Am       Date:  2019-09       Impact factor: 5.982

5.  Bone Loss in HIV Infection.

Authors:  Caitlin A Moran; M Neale Weitzmann; Ighovwerha Ofotokun
Journal:  Curr Treat Options Infect Dis       Date:  2017-02-23

6.  Albumin, white blood cell count, and body mass index improve discrimination of mortality in HIV-positive individuals.

Authors:  Janet P Tate; Jonathan A C Sterne; Amy C Justice
Journal:  AIDS       Date:  2019-04-01       Impact factor: 4.177

7.  Improved fracture prediction using different fracture risk assessment tool adjustments in HIV-infected women.

Authors:  Jingyan Yang; Anjali Sharma; Qiuhu Shi; Kathryn Anastos; Mardge H Cohen; Elizabeth T Golub; Deborah Gustafson; Daniel Merenstein; Wendy J Mack; Phyllis C Tien; Jeri W Nieves; Michael T Yin
Journal:  AIDS       Date:  2018-07-31       Impact factor: 4.177

8.  An increased rate of fracture occurs a decade earlier in HIV+ compared with HIV- men.

Authors:  Anda Gonciulea; Ruibin Wang; Keri N Althoff; Frank J Palella; Jordan Lake; Lawrence A Kingsley; Todd T Brown
Journal:  AIDS       Date:  2017-06-19       Impact factor: 4.177

Review 9.  Osteoporosis in postmenopausal women living with HIV.

Authors:  Fionnuala Finnerty; Karen Walker-Bone; Shema Tariq
Journal:  Maturitas       Date:  2016-11-05       Impact factor: 4.342

10.  Bone Deleterious Effects of Different NRTIs in Treatment-naïve HIV Patients After 12 and 48 Weeks of Treatment.

Authors:  Patricia Atencio; Francisco Miguel Conesa-Buendía; Alfonso Cabello-Ubeda; Patricia Llamas-Granda; Ramón Pérez-Tanoira; Laura Prieto-Pérez; Beatriz Álvarez Álvarez; Irene Carrillo Acosta; Rosa Arboiro-Pinel; Manuel Díaz-Curiel; Raquel Largo; Gabriel Herrero-Beaumont; Miguel Górgolas; Aránzazu Mediero
Journal:  Curr HIV Res       Date:  2021       Impact factor: 1.341

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.